DWP-450

botulinum toxin type A · Daewoong Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for DWP-450, covering 2015-10-05 to 2019-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002 [Phase 3]